These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23150502)

  • 41. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.
    Lutale JJ; Thordarson H; Gulam-Abbas Z; Vetvik K; Gerdts E
    Cardiovasc J Afr; 2008; 19(1):8-14. PubMed ID: 18320079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in hypertensive patients.
    Vernooij JW; Cramer MJ; Visseren FL; Korndewal MJ; Bots ML; Meijs MF; Doevendans PA; Spiering W;
    Am J Cardiol; 2012 Jul; 110(2):227-33. PubMed ID: 22483385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peguero-Lo Presti criteria for diagnosis of left ventricular hypertrophy: a cardiac magnetic resonance validation study.
    Guerreiro C; Azevedo P; Ladeiras-Lopes R; Ferreira N; Barbosa AR; Faria R; Almeida J; Primo J; Melica B; Braga P
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):437-443. PubMed ID: 32251077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis.
    Yu Z; Song J; Cheng L; Li S; Lu Q; Zhang Y; Lin X; Liu D
    PLoS One; 2021; 16(1):e0246305. PubMed ID: 33513186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E; Theofilis P; Mpahara A; Lazaros G; Niarchou P; Vogiatzi G; Tsalamandris S; Fountoulakis P; Christoforatou E; Mystakidou V; Anastasiou M; Goliopoulou A; Tousoulis D
    Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic accuracy of NT-proBNP compared with electrocardiography in detecting left ventricular hypertrophy of hypertensive origin].
    Andrade H; Morillas P; Castillo J; Roldán J; Mateo I; Agudo P; Quiles J; Bertomeu-Martínez V
    Rev Esp Cardiol; 2011 Oct; 64(10):939-41. PubMed ID: 21664755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients.
    Shimizu M; Doi S; Nakashima A; Naito T; Masaki T
    Int J Artif Organs; 2018 Mar; 41(3):135-143. PubMed ID: 29546814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Groningen electrocardiographic criteria for left ventricular hypertrophy: a sex-specific analysis.
    van der Ende MY; Hendriks T; van de Vegte Y; Lipsic E; Snieder H; van der Harst P
    Sci Rep; 2021 Mar; 11(1):6662. PubMed ID: 33758211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The diagnostic performance of mid-regional portion of pro-atrial natriuretic peptide for the detection of left ventricular hypertrophy in Caucasian hypertensive patients.
    Bhandari SS; Davies JE; Struck J; Ng LL
    J Hum Hypertens; 2012 Dec; 26(12):711-5. PubMed ID: 22113442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients.
    Wang D; Xu JZ; Zhang W; Chen Y; Li J; An Y; Bian R; Wang JG
    Am J Hypertens; 2020 Sep; 33(9):831-836. PubMed ID: 32484222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of classic electrocardiographic criteria for left ventricular hypertrophy in an African population.
    Jaggy C; Perret F; Bovet P; van Melle G; Zerkiebel N; Madeleine G; Kappenberger L; Paccaud F
    Hypertension; 2000 Jul; 36(1):54-61. PubMed ID: 10904012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limitations of Electrocardiography for Detecting Left Ventricular Hypertrophy or Concentric Remodeling in Athletes.
    Hedman K; Moneghetti KJ; Hsu D; Christle JW; Patti A; Ashley E; Hadley D; Haddad F; Froelicher V
    Am J Med; 2020 Jan; 133(1):123-132.e8. PubMed ID: 31738876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
    Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
    JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.
    Alfakih K; Walters K; Jones T; Ridgway J; Hall AS; Sivananthan M
    Hypertension; 2004 Aug; 44(2):175-9. PubMed ID: 15226274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
    de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
    Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy.
    Okin PM; Roman MJ; Devereux RB; Pickering TG; Borer JS; Kligfield P
    Hypertension; 1998 Apr; 31(4):937-42. PubMed ID: 9535418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.